UKM Medical Centre   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 4
Founded: Kuala Lumpur Malaysia (1999)

Organization Overview

First Clinical Trial
2005
NCT00204334
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Department of Obstetrics and Gynecology, UKM Medical Centre | Department of Ophthalmology, UKM Medical Centre | PPUKM | UKM Medical Centre | UKM - Medical Department D | UKM- Medical Department D

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Anemia (Phase 4)

Diabetic Retinopathy (Phase 4)

Endophthalmitis (Phase 2)

Infarction (Phase 2)

Infarction, Middle Cerebral Artery (Phase 2)

Ischemia (Phase 2)

Kidney Diseases (Phase 4)

Osteoarthritis (Phase 2)

Osteoarthritis, Knee (Phase 2)

Renal Insufficiency, Chronic (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 14
  • # of Trial APIs: 16